Daniel M. Takefman

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

Lindsey A. George, Spencer K. Sullivan, Adam Giermasz et al. · New England Journal of Medicine · 2017 · 759 citations · Full text

Medicine, Hematology, Molecular Medicine +15

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo

B L Sullivan, E J Knopoff, Mohammed Saifuddin et al. · The Journal of Immunology · 1996 · 105 citations

Life Sciences, Immunology, Infectious Diseases +15

Complement activation by human monoclonal antibodies to human immunodeficiency virus

Gregory T. Spear, Daniel M. Takefman, B L Sullivan et al. · Journal of Virology · 1993 · 73 citations · Full text

Pharmacy, Immunology, Infectious Diseases +15

Immune Complexes Containing Human Immunodeficiency Virus Type 1 Primary Isolates Bind to Lymphoid Tissue B Lymphocytes and Are Infectious for T Lymphocytes

Jocelyn Jakubik, Mohammed Saifuddin, Daniel M. Takefman et al. · Journal of Virology · 2000 · 64 citations

Life Sciences, Immunology, Infectious Diseases +12

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Katherine A. High, Lindsey A. George, M. Elaine Eyster et al. · Blood · 2018 · 60 citations

Medicine, Hematology, Immunology +15